Gene · 10491
Papers1,478
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
181 to 200 of 1,478
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The Proteome Profile of Olfactory Ecto-Mesenchymal Stem Cells-Derived from Patients with Familial Alzheimer's Disease Reveals New Insights for AD Study. | Int J Mol Sci | 2023 | 37628788 | PubTator, text mining | PubMed |
| Clinical and molecular description of the first Italian cohort of 33 subjects with hypophosphatasia. | Front Endocrinol (Lausanne) | 2023 | 37600704 | PubTator, text mining | PubMed |
| Zoledronic Acid Treatment in Infants and Toddlers with Osteogenesis Imperfecta is Safe and Effective: A Tertiary Care Centre Experience. | Indian J Endocrinol Metab | 2023 | 37583407 | PubTator, text mining | PubMed |
| Pathogenic mechanisms of osteogenesis imperfecta, evidence for classification. | Orphanet J Rare Dis | 2023 | 37559063 | PubTator, text mining | PubMed |
| Systemic inflammatory proteins in offspring following maternal probiotic supplementation for atopic dermatitis prevention. | Clin Mol Allergy | 2023 | 37516841 | PubTator, text mining | PubMed |
| Gene-repaired iPS cells as novel approach for patient with osteogenesis imperfecta. | Front Bioeng Biotechnol | 2023 | 37456734 | PubTator, text mining | PubMed |
| Natural resveratrol analogs differentially target endometriotic cells into apoptosis pathways. | Sci Rep | 2023 | 37454164 | PubTator, text mining | PubMed |
| Prognostic Implications of Physical Activity on Mortality from Ischaemic Heart Disease: Longitudinal Cohort Study Data. | J Clin Med | 2023 | 37445253 | PubTator, text mining | PubMed |
| Osteogenesis imperfecta type VIII: highlighting the need for genetic testing. | BMJ Case Rep | 2023 | 37437959 | PubTator, text mining | PubMed |
| Multimorbidity and Quality of Life: The Mediating Role of ADL, IADL, Loneliness, and Depressive Symptoms. | Innov Aging | 2023 | 37435089 | PubTator, text mining | PubMed |
| SERPINF1 gene variants causing late-onset progressive deforming osteogenesis imperfecta - A study of 18 patients from India. | Bone Rep | 2023 | 37425194 | PubTator, text mining | PubMed |
| Compensatory cross-talk between autophagy and glycolysis regulates senescence and stemness in heterogeneous glioblastoma tumor subpopulations. | Acta Neuropathol Commun | 2023 | 37420311 | PubTator, text mining | PubMed |
| Pharmacological Cardioprotection against Ischemia Reperfusion Injury-The Search for a Clinical Effective Therapy. | Cells | 2023 | 37408266 | PubTator, text mining | PubMed |
| Discovering Potential Anti-Oral Squamous Cell Carcinoma Mechanisms from Kochiae Fructus Using Network-Based Pharmacology Analysis and Experimental Validation. | Life (Basel) | 2023 | 37374083 | PubTator, text mining | PubMed |
| Reviewing the Regulators of COL1A1. | Int J Mol Sci | 2023 | 37373151 | PubTator, text mining | PubMed |
| Multidisciplinary inpatient rehabilitation for older adults with COVID-19: a systematic review and meta-analysis of clinical and process outcomes. | BMC Geriatr | 2023 | 37365515 | PubTator, text mining | PubMed |
| Improvement of protein tertiary and quaternary structure predictions using the ReFOLD refinement method and the AlphaFold2 recycling process. | Bioinform Adv | 2023 | 37359722 | PubTator, text mining | PubMed |
| Estimation of model accuracy in CASP15 using the ModFOLDdock server. | Proteins | 2023 | 37314190 | PubTator, text mining | PubMed |
| Structure Characterization, In Vitro Antioxidant and Anti-Tumor Activity of Sulfated Polysaccharide from Siraitia grosvenorii. | Foods | 2023 | 37297378 | PubTator, text mining | PubMed |
| Assessment of validity and comparison of two Spanish versions of the Geriatric Depression Scale. | Front Psychol | 2023 | 37265959 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/10491/papers?page=10